Mineralization, Structure and Function of Bone

Dynamics of Bone and Cartilage Metabolism

Volumn , Issue , 2006, Pages 201-212

  Boskey, Adele L ^a,b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951234753     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088562-6/50013-3     Document Type: Chapter

References (102)

1. Reith E.J., Ross M.J. Atlas of Descriptive Histology 1970, 23-40. Harper and Row, Publishers, Hagerstown MD. Second Edition.
2. Wolff J. The Law of Bone Remodelling 1986, Translated from the original 1892 edition, by P. Maquet and R. Furlong, Springer-Verlag, Berlin.
3. Glimcher M.J. The nature of the mineral phase in bone: biological and clinical implications. Metabolic Bone Disease and Clinically Related Disorders 1998, 23-50. Academic Press, San Diego. L.V. Avioli, S.M. Krane (Eds.).
4. Holden J.L., Clement J.G., Phakey P.P. Age and temperature related changes to the ultrastructure and composition of human bone mineral. J. Bone Miner. Res. 1995, 10:1400-1409.
5. Loong C.K., Rey C., Kuhn L.T., Combes C., Wu Y., Chen S., Glimcher M.J. Evidence of hydroxyl-ion deficiency in bone apatites: an inelastic neutron-scattering study. Bone 2000, 26:599-602.
6. Tong W., Glimcher M.J., Katz J.L., Kuhn L., Eppell S.J. Size and shape of mineralites in young bovine bone measured by atomic force microscopy. Calcif. Tissue Int. 2003, 72:592-598.
7. Fratzl P., Schreiber S., Klaushofer K. Bone mineralization as studied by small-angle x-ray scattering. Connect. Tissue Res. 1996, 34:247-254.
8. Kim H-M., Rey C., Glimcher M.J. Isolation of calcium-phosphate crystals of bone by nonaqueous methods of low temperature. J. Bone Miner. Res. 1995, 10:1589-1660.
9. Landis W.J., Hodgens K.J., Arena J., Song M.J., McEwen B.F. Structural relations between collagen and mineral in bone as determined by high voltage electron microscopic tomography. Microsc. Res. Tech. 1996, 33:192-202.
10. Boyde A., Jones S.J. Scanning electron microscopy of bone: instrument, specimen, and issues. Microsc. Res. Tech. 1996, 33:92-120.
11. Paschalis E.P., DiCarlo E., Betts F., Sherman P., Mendelsohn R., Boskey A.L. FTIR microspectroscopic analysis of human osteonal bone. Calcif. Tissue Int. 1996, 59:480-487.
12. Tamowski C.P., Ignelzi M.A., Morris M.D. Mineralization of developing mouse calvaria as revealed by Raman microscpectroscopy. J. Bone Miner. Res. 2002, 17:1118-1126.
13. Roughley P.J., Rauch F., Glorieux F. Osteogenesis imperfecta-clinical and molecular diversity. Eur. Cell Mater. 2003, 5:41-47.
14. Camacho N.P., Raggio C.L., Doty S.B., Root L., Zraick V., Ilg W.A., Toledano T.R., Boskey A.L. A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif. Tissue Int. 2001, 69:94-101.
15. Gokhale J., Robey P.G., Boskey A.L. The Biochemistry of Bone. Osteoporosis 2001, Volume 1:107-189. Academic Press, San Diego. Second Edition. R. Marcus, D. Feldman, J. Kelsey (Eds.).
16. Reddi A.H. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng. 2000, 6:351.
17. Schmid T.M., Bonen D.K., Luchene L., Linsenmayer T.F. Late events in chondrocyte differentiation: hypertrophy, type X collagen synthesis and matrix calcification. In Vivo. 1991, 5:533-540.
18. Anderson H.C. Matrix vesicles and calcification. Curr. Rheumatol. Rep. 2003, 5:222-226.
19. Ortega N., Behonick D., Stickens D., Werb Z. How proteases regulate bone morphogenesis. Ann. N.Y. Acad. Sci. 2003, 995:109-116.
20. Wu L.N., Genge B.R., Dunkelberger D.G., LeGeros R.Z., Concannon B., Wuthier R.E. Physicochemical characterization of the nucleational core of matrix vesicles. J. Biol. Chem. 1997, 272:4404-4411.
21. Buckwalter J.A., Rosenberg L.C. Structural changes during development in bovine fetal epiphyseal cartilage. Collagen Relat. Res. 1983, 3:489-504.
22. Cowles E.A., DeRome M.E., Pastizzo G., Brailey L.L., Gronowicz G.A. Mineralization and the expression of matrix proteins during in vivo bone development. Calif. Tissues Int. 1998, 62:74-82.
23. Ramstad V.E., Franzen A., Heinegard D., Wendel M., Reinholt F.P. Ultrastructural distribution of osteoadherin in rat bone shows a pattern similar to that of bone sialoprotein. Calcif. Tissue Int. 2003, 72:57-64.
24. Vogel K.G., Paulsson M., Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 1984, 223:587-597.
25. Kuboki Y., Kudo A., Mizuno M., Kawamura M. Time-dependent changes of collagen cross-links and their precursors in culture of osteogeneic cells. Calcif. Tissue Int. 1992, 50:473-480.
26. Eyre D.R., Dickson I.R., Van Ness K. Collagen crosslinking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem. J. 1988, 252:495-500.
27. Gerstenfeld L.C., Chipman S.D., Glowacki J., Lian J.B. Expression to differentiate function by mineralizing cultures of chicken osteoblasts. Dev. Biol. 1986, 122:49-60.
28. Hauschka P.V., Wians F.H. Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat. Res. 1989, 224:180-188.
29. Wu Y., Ackerman J.L., Strawich E.S., Rey C., Kim H.M., Glimcher M.J. Phosphate ions in bone: identification of a calcium-organic phosphate complex by 31P solid-state NMR spectroscopy at early stages of mineralization. Calcif. Tissue Int. 2003, 72:610-626.
30. Mbuyi-Muamba J.M., Dequeker J., Gevers G. Collagen and noncollagenous proteins in different mineralization stages of human femur. Acta Anat. (Basel). 1989, 134:265-268.
31. Lane J.M., Betts F., Posner A.S., Yue D.W. Mineral parameters in early fracture repair. J. Bone Joint Surg. [Am] 1984, 66:1289-1293.
32. Boskey A.L., Marks S.C. Mineral and matrix alterations in the bones of incisors-absent (ia/ia). Osteopetrotic rat. Calcif. Tissue Int. 1985, 37:287-292.
33. Kuhn L.T., Wu Y., Rey C., Gerstenfeld L.C., Grynpas M.D., Ackerman J.L., Kim H.M., Glimcher M.J. Structure, composition, and maturation of newly deposited calcium-phosphate crystals in chicken osteoblast cell cultures. J. Bone Miner. Res. 2000, 15:1301-1309.
34. Mendelsohn R., Hassenkhani A., DiCarlo E., Boskey A.L. FT-IR microscopy of endochondral ossification at 20? spatial resolution. Calcif. Tissue Int. 1989, 44:20-24.
35. Weiss I.M., Tuross N., Addadi L., Weiner S. Mollusc larval shell formation: amorphous calcium carbonate is a precursor phase for aragonite. J. Exp. Zool. 2002, 293:478-491.
36. Driessens F.C.M., Verbeeck R.M.H. Biominerals 1990, 37-61. Ch 3, CRC Press, Boca Raton, FL.
37. Traub W., Arad T., Weiner S. Origin of mineral crystal growth in collagen fibrils. Matrix. 1992, 12:251-255.
38. Garimella R., Bi X., Camacho N., Spie J.B., Anderson H.C. Primary culture of rat growth plate chondrocytes: an in vitro model of growth plate histotype, matrix vesicle biogenesis and mineralization. Bone 2004, 34:961-970.
39. Eanes E.D., Hailer A.W., Midura R.J., Hascall V.C. Proteoglycan inhibition of calcium phosphate precipitation in liposomal suspensions. Glycobiology 1992, 2:571-578.
40. Boskey A.L., Maresca M., Armstrong A.L., Ehrlich M.G. Treatment of proteoglycan aggregates with growth plate neutral metalloprotease reduces their ability to inhibit hydroxyapatite proliferation in a gelatin gel. J. Orthop. Res. 1992, 10:313-319.
41. Embery G., Hall R., Waddington R., Septier D., Goldberg M. Proteoglycans in dentinogenesis. Crit. Rev. Oral Biol. Med. 2001, 12:331-349.
42. Cornelissen M., de Ridder L. Electron microscopic study of proteoglycan aggregates synthesized by embryonic chick sternal chondrocytes in vitro. Eur. J. Morphol. 1993, 31:17-20.
43. Dean D.D., Boyan B.D., Muniz O.E., Howell D.S., Schwartz Z. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner. Calcif. Tissue Int. 1996, 59:109-116.
44. Anderson H.C., Sipe J.B., Hessle L., Dhanyamraju R., Atti E., Camacho N.P., Millan J.L. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am. J. Pathol. 2004, 164:841-847.
45. Luckman S.P., Rees E., Kwan A.P. Partial characterization of cell-type X collagen interactions. Biochem. J. 2003, 372:485-493.
46. Landis W.J., Hodgens K.J., McKee M.D., Nanci A., Song M.J., Kiyonaga S., Arena J., McEwen B. Extracellular vesicles of calcifying turkey leg tendon characterized by immunocytochemistry and high voltage electron microscopic tomography and 3-D graphic image reconstruction. Bone Miner. 1992, 17:237-241.
47. Mocetti P., Ballanti P., Zalzal S., Silvestrini G., Bonucci E., Nanci A. A histomorphometric, structural, and immunocytochemical study of the effects of diet-induced hypocalcemia on bone in growing rats. J. Histochem. Cytochem. 2000, 48:1059-1078.
48. Glimcher M.J., Hodge A.J., Schmitt F.O. Macromolecular aggregation states in relation to mineralization: the collagen hydroxyapatite system as studied in vitro. Proc. Natl Acad. Sci. U.S.A. 1957, 43:860-967.
49. Mergenhagen S.E., Martin G.R., Rizzo A., Wright D.N., Scott D.B. Calcification in vivo of implanted collagens. Biochim. Biophys. Acta. 1960, 43:563-565.
50. Termine J.D., Kleinman H.K., Whitson S.W., Conn K.M., McGarvey M.L., Martin G.R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 1981, 26:99-105.
51. Endo A., Glimcher M.J. The effect of complexing phosphoproteins to decalcified collagen on in vitro calcification. Connect. Tissue Res. 1989, 21:179-190.
52. de Bri E., Reinholt F.P., Heinegard D., Mengarelli-Widholm S., Norgard M., Svensson O. Bone sialoprotein and osteopontin distribution at the osteocartilaginous interface. Clin. Orthop. Relat. Res. 1996, 330:251-260.
53. Stein G.S., Lian J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Res. 1993, 14:424-442.
54. Young M.F., Bi Y., Ameye L., Chen X.D. Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj. J. 2002, 19:257-262.
55. McKee M.D., Nanci A. Postembedding colloidal-gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues. Microsc. Res. Tech. 1995, 31:44-62.
56. Fisher L.W., Fedarko N.S. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect. Tissue Res. 2003, 44:33-40.
57. Jain A., Karadag A., Fohr B., Fisher L.W., Fedarko N.S. Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J. Biol. Chem. 2002, 277:13700-13708.
58. Fedarko N.S., Jain A., Karadag A., Fisher L.W. Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J. 2004, 18:734-746.
59. Wu L.N., Sauer G.R., Genge B.R., Valhmu W.B., Wuthier R.E. Effects of analogues of inorganic phosphate and sodium ion on mineralization of matrix vesicles isolated from growth plate cartilage of normal rapidly growing chickens. J. Inorg. Biochem. 2003, 94:221-235.
60. Pampena D.A., Robertson K.A., Litvinova O., Lajoie G., Goldberg H.A., Hunter G.K. Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem. J. 2004, 378:1083-1087.
61. Silveman L., Boskey A.L. Diffusion systems for evaluation of biomineralization. Calcified Tissue Int. 2004, 75:494-501.
62. Ganss B., Kim R.H., Sodek J. Bone sialoprotein. Crit. Rev. Oral Biol. Med. 1999, 10:79-98.
63. Hunter G.K., Goldberg H.A. Nucleation of hydroxyapatite by bone sialoprotein. Proc. Natl Acad. Sci. USA 1993, 90:8562-8565.
64. Midura R.J., Wang A., Lovitch D., Law D., Powell K., Gorski J.P. Bone acidic glycoprotein-75 delineates the extracellular sites of future bone sialoprotein accumulation and apatite nucleation in osteoblastic cultures. J. Biol. Chem. 2004, 279:25464-25473.
65. Stubbs J.T., Mintz K.P., Eames E.D., Torchia D.A., Fisher L.W. Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. J. Bone Miner. Res. 1997, 12:1210-1222.
66. Fujisawa R., Wada Y., Nodasaka Y., Kuboki Y. Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim. Biophys. Acta. 1996, 1292:53-60.
67. Tye C.E., Rattray K.R., Warner K.J., Gordon J.A., Sodek J., Hunter G.K., Goldberg H.A. Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J. Biol. Chem. 2003, 278:7949-7955.
68. Boskey A.L., Spevak L., Doty S.B., Rosenberg L. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif. Tissue Int. 1997, 61:298-305.
69. Tartaix P.H., Doulaverakis M., George A., Fisher L.W., Butler W.T., Qin C., Salih E., Tan M., Fujimoto Y., Spevak L., Boskey A.L. Dentin matrix protein-1: In vitro effects on hydroxyapatite formation provide insights into in vivo functions. J. Biol. Chem. 2004, 279:18115-18120.
70. Boskey A.L., Maresca M., Doty S., Sabsay B., Veis A. Concentration dependent effects of dentin-phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone Mineral 1990, 11:55-65.
71. Boskey A.L., Maresca M., Ulrich W., Doty S.B., Butler W.T., Prince C.W. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner. 1993, 22:147-159.
72. Hunter G.K., Kyle C.L., Goldberg H.A. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem. J. 1994, 300:723-728.
73. Rowe P.S., Kumagai Y., Gutierrez G., Garrett I.R., Blacher R., Rosen D., Cundy J., Navvab S., Chen D., Drezner M.K., Quarles L.D., Mundy G.R. MEPE has the properties of an osteoblastic phosphatonin and inhibin. Bone 2004, 34:303-319.
74. Prince M., Banerjee C., Javed A., Green J., Lian J.B., Stein G.S., Bodine P.V., Komm B.S. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J. Cell. Biochem. 2001, 80:424-440.
75. Boskey A.L., Stiner D., Binderman I., Doty S.B. Effects of proteoglycan modification on mineral formation in a differentiating chick limb-bud mesenchymal cell culture system. J. Cell Biochem. 1997, 64:632-643.
76. Boskey A.L., Guidon P., Doty S.B., Stiner D., Leboy P., Binderman I. The mechanism of ?-glycerophosphate action in mineralizing chick limb-bud mesenchymal cells. J. Bone Min. Res. 1996, 11:1694-1702.
77. Luppen C.A., Leclerc N., Noh T., Barski A., Khokhar A., Boskey A.L., Smith E., Frenkel B. Brief bone morphogenetic protein 2 treatment of lucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J. Biol. Chem. 2003, 278:44995-45003.
78. Thomas G., Moffatt P., Salois P., Gaumond M.H., Gingras R., Godin E., Miao D., Goltzman D., Lanctot C. Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J. Biol. Chem. 2003, 278:50563-50571.
79. Schinke T., Amendt C., Trindl A., Poschke O., Muller-Esterl W., Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J. Biol. Chem. 1996, 271:20789-20796.
80. Stacey A., Bateman J., Choi T., Mascara T., Cole W., Jaenisch R. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha I(i) collagen gene. Nature 1988, 332:131-136.
81. Gowen L.C., Petersen D.N., Mansolf A.L., Qi H., Stock J.L., Tkalcevic G.T., Simmons H.A., Crawford D.T., Chidsey-Frink K.L., Ke H.Z., McNeish J.D., Brown T.A. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J. Biol. Chem. 2003, 278:1998-2007.
82. Forlino A., Porter F.D., Lee E.J., Westphal H., Marini J.C. Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alphal(I) G349C substitution. Variability in phenotype in BrtIIV mice. J. Biol. Chem. 1999, 274:37923-37931.
83. Watanabe H., Yamada Y. Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nat. Genet. 1999, 21:225-229.
84. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1 alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl Acad. Sci. USA 2001, 98:7498-7503.
85. Xu T., Bianco P., Fisher L.W., Longenecker G., Smith E., Goldstein S., Bonadio J., Boskey A., Heegaard A.M., Sommer B., Satomura K., Dominguez P., Zhao C., Kulkami A.B., Robey P.G., Young M.F. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 1998, 20:78-82.
86. Boskey A.L., Spevak L., Paschalis E., Doty S.B., McKee M.D. Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif. Tissue Int. 2002, 71:145-154.
87. Boskey A.L., Karsenty G., McKee M.D. Mineral characterization of bones and soft tissues in matrix gla protein deficient mice. Am. Acad. Orthopaed. Surgeons., Chicago, IL 2000, 63-67.
88. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
89. Boskey A.L., Gadaleta S., Gundberg C., Doty S.B., Ducy P., Karsenty G. FT-IR microspectroscopic analysis of bones of osteocalcin-deficient mice provided insight into the function of osteocalcin. Bone 1998, 23:187-196.
90. Boskey A.L., Moore D.J., Amling M., Canalis E., Delany A.M. Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J. Bone Miner. Res. 2003, 18:1005-1011.
91. Paschalis E.P., Jacenko O., Olsen B., Mendelsohn R., Boskey A.L. Fourier transform infrared microspectroscopic analysis identifies alterations in mineral properties in bones from mice transgenic for type X collagen. Bone 1996, 19:151-156.
92. Giachelli C.M., Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000, 19:615-622.
93. Denhardt D.T., Noda M., O'Regan A.W., Pavlin D., Berman J.S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 2001, 107(9):1055-1061.
94. Dequeker J., Mundy G.R. Bone structure and function. Rheumatology 1998, 1-12. Mosby, London. Second Edition. J.H. Klippel, P.A. Dieppe (Eds.).
95. Bigi A., Cojazzi G., Panzavolta S., Ripamonti A., Roveri N., Romanello M., Noris Suarez K., Moro L. Chemical and structural characterization of the mineral phase from cortical and trabecular bone. J. Inorg. Biochem. 1997, 68:45-51.
96. Jilka R.L. Biology of the basic multicellular unit and the pathophysiology of osteoporosis. Med. Pediatr. Oncol. 2003, 41:182-185.
97. Yoshitake H., Rittling S.R., Denhardt D.T., Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc. Natl Acad. Sci. USA 1999, 96:8156-8160.
98. Raisz L.G. Physiology and pathophysiology of bone remodeling. Clin. Chem. 1999, 45:1353-1358.
99. Cheng X., Kinosaki M., Murali R., Greene M.J. The TNF receptor superfamily: role in immune inflammation and bone formation. Immunol. Res. 2003, 27:287-294.
100. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
101. Hashimoto-Gotoh T., Ohnishi H., Tsujimura A., Tsunezuka H., Imai K., Masuda H., Nakamura T. Bone mass increase specific to the female in a line of transgenic mice overexpressing human osteoblast stimulating factor-1. J. Bone Miner. Metab. 2004, 22:278-282.
102. Kozloff K.M., Carden A., Bergwitz C., Forlino A., Uveges T.E., Morris M.D., Marini J.C., Goldstein S.A. Brittle IV mouse model for osteogenesis imperfectal IV demonstrates postpubertal adaptations to improve whole bone strength. J. Bone Miner. Res. 2004, 19:614-622.